• Explore /
  • Poster
  • / A phase Ib dose escalation, safety, and tolerability study of sonidegib in combination with gemcitabine in patients with locally advanced or metastatic pancreatic adenocarcinoma.

A phase Ib dose escalation, safety, and tolerability study of sonidegib in combination with gemcitabine in patients with locally advanced or metastatic pancreatic adenocarcinoma.

Abstract Poster

Authors

null

Teresa Macarulla

Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain

Teresa Macarulla , Josep Tabernero , Daniel H. Palmer , Sunil Sharma , Kenneth H. Yu , Dalila B. Sellami , Jocelyn Zhou , Wu Yi , Hildegard Boss , Eunice L Kwak

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT01487785

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr 371)

DOI

10.1200/jco.2016.34.4_suppl.371

Abstract #

371

Poster Bd #

J7

Abstract Disclosures

Similar Posters

First Author: Beate Schultheis

First Author: Chris Verslype

First Author: Dong-Sheng Zhang

First Author: Li-Yuan Bai